Zahi Mitri - Concepedia

Author

Zahi Mitri

Oregon Health & Science University ORCID

Also Known As

Claudine Isaacs, Gordon B. Mills, Z Mitri, Z. Mitri, Zahi I Mitri, Zahi I. Mitri, Zahi Ibrahim Mitri, Zahi Mitri

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University The University of Texas MD Anderson Cancer Center OHSU Knight Cancer Institute University of Pennsylvania American University of Beirut

About

Zahi Mitri is an author at Oregon Health & Science University specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	352
2	Health Sciences	2	2	59
3	Cell Biology	2	2	92
4	Public Health	1	1	35
5	Applied Physiology	1	1	43

Zahi Mitri

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy Zahi Mitri, Tina Constantine, Ruth O’Regan Chemotherapy Research and Practice	2012	515
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer Zahi Mitri, Cansu Karakaş, Caimiao Wei, Investigational New Drugs Breast OncologyMedicinePharmacologyCdk Inhibitor DinaciclibBreast Cancer	2015	88
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors Matthew S. Dietz, Thomas L. Sutton, Brett S. Walker, Scientific Reports ImmunologyBiological MicroenvironmentsPathologyImmunoeditingCancer Biology	2021	73
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy Madeline Cook, Luai Al Rabadi, Andy Kaempf, The Oncologist	2020	56
CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real‐world practice Malinda West, Claire E.P. Smith, Andy Kaempf, European Journal Of Haematology	2021	55
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib R. Charles Coombes, Sacha J. Howell, Simon Lord, Nature Communications	2023	54
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer Brett Johnson, Allison Creason, Jayne M. Stommel, Cell Reports Medicine	2022	51
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise? Kerri M. Winters‐Stone, Cassie Boisvert, Fuzhong Li, Supportive Care in Cancer	2021	49
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics Allen Li, Jamie M. Keck, Swapnil Parmar, npj Precision Oncology	2021	44
A randomized-controlled trial comparing supervised aerobic training to resistance training followed by unsupervised exercise on physical functioning in older breast cancer survivors Kerri M. Winters‐Stone, Britta Torgrimson-Ojerio, Nathan F. Dieckmann, Journal of Geriatric Oncology Physical ActivityKinesiologyPhysical FitnessExerciseExercise Physiology	2021	43

Page 1